Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/12/1997 | WO1997026320A3 Product for inhibition of attachment of h. influenzae to human cells |
09/12/1997 | WO1997025421A3 PROTEIN INDUCED BY DEPRENYL$m(3) |
09/12/1997 | WO1997024436A3 Ligand polypeptides for the g-protein-coupled receptor protein, their production and use |
09/12/1997 | WO1997023624A3 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
09/12/1997 | WO1997023598A3 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
09/12/1997 | WO1997022698A3 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
09/12/1997 | WO1997022690A3 SIGNALING INOSITOL POLYPHOSPHATE 5-PHOSPHATASES (SIPs) |
09/12/1997 | WO1997021826A3 Complementary adenoviral vector systems and cell lines |
09/12/1997 | WO1997017457A3 Stable packaging cell line producing pseudotyped retroviruses |
09/12/1997 | WO1997017455A3 Commercial production of avidin in plants |
09/12/1997 | WO1997011690A3 Inhibitors of regulatory pathways |
09/12/1997 | WO1997008199A3 Antimicrobial cationic peptides and methods of screening for the same |
09/12/1997 | WO1997004097A3 Human CTLA-8 and uses of CTLA-8-related proteins |
09/12/1997 | CA2248555A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages |
09/12/1997 | CA2248535A1 Nucleic acid molecules coding for debranching enzymes from maize |
09/12/1997 | CA2248350A1 Inhibition of proliferation of cells |
09/12/1997 | CA2248264A1 Malignant human cell transformation detection method |
09/12/1997 | CA2248248A1 Alpha-galactosidase |
09/12/1997 | CA2248095A1 Transferrin receptor genes of moraxella |
09/12/1997 | CA2248023A1 Process for the production of degradation and/or conversion products of storage substances present in transgenic plant material with the help of a malting process |
09/12/1997 | CA2247912A1 Genetically engineered primary oligodendrocytes for transplantation-mediated gene delivery in the central nervous system |
09/12/1997 | CA2247806A1 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
09/12/1997 | CA2247615A1 Down-regulation resistant c3 convertase |
09/12/1997 | CA2247480A1 Oligonucleotide analogues |
09/12/1997 | CA2247099A1 Methods for transducing cells in blood vessels using recombinant aav vectors |
09/12/1997 | CA2247091A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
09/12/1997 | CA2246333A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
09/12/1997 | CA2244733A1 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells |
09/11/1997 | DE19608918A1 Nucleinsäuremoleküle, die neue Debranching-Enzyme aus Mais codieren Nucleic acid molecules encoding new debranching enzymes from maize |
09/11/1997 | DE19608751A1 Adeno-assoziierter Virus-Vektor zur Steigerung der Immunogenität von Zellen Adeno-associated virus vector for enhancing the immunogenicity of cells |
09/10/1997 | EP0794257A1 Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino aced sequence and vaccine containing same |
09/10/1997 | EP0794256A2 Method for culturing microorganisms having methanol metabolic pathway |
09/10/1997 | EP0794255A2 Method for cleaving chimeric protein using processing enzyme |
09/10/1997 | EP0794254A2 Process for production of secretory kex2 derivatives |
09/10/1997 | EP0794253A2 Aminopeptidase GX, and a method of hydrolyzing a protein with the same |
09/10/1997 | EP0794252A2 Method for cloning and producing the PshAI restriction endonuclease |
09/10/1997 | EP0794251A1 D-pantolactone hydrolase and gene encoding the same |
09/10/1997 | EP0794250A1 Isolation and sequencing of the hazel FAd2-N gene |
09/10/1997 | EP0794001A2 Automated system for polynucleotide synthesis and purification |
09/10/1997 | EP0793730A1 A high-throughput screening assay for inhibitors of nucleic acid polymerases |
09/10/1997 | EP0793729A1 Lyophilized bioluminescent bacterial reagent for the detection of toxicants |
09/10/1997 | EP0793728A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
09/10/1997 | EP0793727A1 Production of variant nisin |
09/10/1997 | EP0793726A1 A process for producing polypeptides with reduced allergenicity |
09/10/1997 | EP0793725A1 Nuclear protein serine/threonine kinases |
09/10/1997 | EP0793724A2 Oxidoreductase from filamentous fungi, dna coding therefor and cells transformed with said dna |
09/10/1997 | EP0793723A2 New staphylokinase derivatives |
09/10/1997 | EP0793722A2 Modified proteinase inhibitors |
09/10/1997 | EP0793721A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
09/10/1997 | EP0793719A2 Rna component of telomerase |
09/10/1997 | EP0793718A1 Molecular tagging system |
09/10/1997 | EP0793717A1 Oral immunization with transgenic plants |
09/10/1997 | EP0793713A1 Adeno-associated derived vector systems for gene delivery and integration into target cells |
09/10/1997 | EP0793677A1 Anti-inflammatory cd14 polypeptides |
09/10/1997 | EP0793675A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
09/10/1997 | EP0793672A1 Expressed chemokines, their production and uses |
09/10/1997 | EP0793509A1 Viral vector complexes having adapters of predefined valence |
09/10/1997 | EP0793508A1 Novel nucleic acid molecules comprising the prostate specific antigen (psa) promoter and uses thereof |
09/10/1997 | EP0793504A1 Chimeric cytokines and uses thereof |
09/10/1997 | EP0793503A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
09/10/1997 | EP0793502A1 Novel hedgehog-derived polypeptides |
09/10/1997 | EP0793501A1 In vivo activation of tumor-specific cytotoxic t cells |
09/10/1997 | EP0725800A4 cDNA ENCODING A NOVEL HUMAN PROTEIN TYROSINE PHOSPHATASE |
09/10/1997 | EP0669001B1 Determination of peptide motifs on mhc molecules |
09/10/1997 | EP0546073B1 production and use of transgenic non-human animals capable of producing heterologous antibodies |
09/10/1997 | EP0487711B1 Apparatus for genetic transformation |
09/10/1997 | EP0466833B1 Protease inhibitor |
09/10/1997 | CN1159211A System of probes intended to carry out the typing HLA DR, and typing process using said probes |
09/10/1997 | CN1159210A Non self-inactivating, Expression targeted retroviral vectors |
09/10/1997 | CN1159209A Recombinant herpesvirus with the use of gB Gene promoter |
09/10/1997 | CN1159206A Production and secretion of recombinant fibrinogen by yeast |
09/10/1997 | CN1159143A Insect control method with genetically engineered biopesticides |
09/10/1997 | CN1158898A Transfection of cells |
09/10/1997 | CN1158897A Actinomycete promoter |
09/10/1997 | CN1158896A Novel stress proteins |
09/10/1997 | CN1158895A Human liver proliferating agent |
09/10/1997 | CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
09/10/1997 | CN1035799C Process for regeneration of cotton |
09/09/1997 | US5665892 Isolated dna encoding sucrose phosphate synthetase derived from corn |
09/09/1997 | US5665879 Amphiphilic derivatives of piperazine |
09/09/1997 | US5665873 Inhibits reactivation of herpes virus |
09/09/1997 | US5665872 Dna having specified nucleotide sequence |
09/09/1997 | US5665870 Method of purifying keratinocyte growth factor (KGF) |
09/09/1997 | US5665866 Process for obtaining antibodies utilizing heat treatment |
09/09/1997 | US5665865 Metal binding proteins |
09/09/1997 | US5665863 Coupled to albumin; genetic engineering |
09/09/1997 | US5665862 Neurotrophic factor |
09/09/1997 | US5665859 Molecules influencing the shedding of the TNF receptor, their preparation and their use |
09/09/1997 | US5665762 Decontaminating clinical samples |
09/09/1997 | US5665600 Pichia pastoris linear plasmids and DNA fragments thereof |
09/09/1997 | US5665593 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
09/09/1997 | US5665587 Modified subtilisins and detergent compositions containing same |
09/09/1997 | US5665586 Protease from Streptomyces fradiae |
09/09/1997 | US5665585 High debranching activity |
09/09/1997 | US5665584 DNA fragment containing a tannase gene, a recombinant plasmid, a process for producing tannase, and a promoter |
09/09/1997 | US5665583 Methods and materials relating to IMPDH and GMP production |
09/09/1997 | US5665582 Isolation of biological materials |
09/09/1997 | US5665581 Attenuation of fungal virulence by synthetic infectious mycovirus transcripts |
09/09/1997 | US5665580 Antisense oligonucleotide inhibition of papillomavirus transformed cells |
09/09/1997 | US5665579 Invertase genes and uses thereof |